The global immunoprecipitation market is expected to grow at a CAGR of 5.5% during the forecast period, from 2021 to 2030. The individual IP segment is expected to account for the largest share of the global immunoprecipitation market in terms of revenue, followed by coimmunoprecipitation and CHIP segments. The individual IP segment is projected to grow at a CAGR of 6.2% during the forecast period, from 2021 to 2030. North America accounted for the largest share in terms of revenue in 2018 and is expected to continue its dominance throughout the forecast period, owing primarily due to high adoption rates among research institutes and pharmaceutical companies in this region. Europe accounted for second-largest share in terms of revenue and Asia Pacific was third-largest contributor with respect to revenue generation during 2018.
- The market for immunoprecipitation is expected to reach $3,890 million by 2022.
- Immunoprecipitation is used in the diagnosis and treatment of various diseases such as cancer, HIV/AIDS, and hepatitis.
- Immunoprecipitation can be used in the detection of infectious agents such as bacteria and viruses.
- Immunoprecipitation can be used in the detection of genetic mutations.
Industry Growth Insights published a new data on “Immunoprecipitation Market”. The research report is titled “Immunoprecipitation Market research by Types (Individual IP, Coimmunoprecipitation, CHIP), By Applications (Academics, Research Institutes, Pharmaceutical and Biotechnology Companies), By Players/Companies Thermo Fisher Scientific, Abcam, Merck KGaA, Agarose Bead Technologies, ...”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Immunoprecipitation Market Research Report
By Type
Individual IP, Coimmunoprecipitation, CHIP
By Application
Academics, Research Institutes, Pharmaceutical and Biotechnology Companies
By Companies
Thermo Fisher Scientific, Abcam, Merck KGaA, Agarose Bead Technologies, ...
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
241
Number of Tables & Figures
169
Customization Available
Yes, the report can be customized as per your need.
Global Immunoprecipitation Market Report Segments:
The global Immunoprecipitation market is segmented on the basis of:
Types
Individual IP, Coimmunoprecipitation, CHIP
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Academics, Research Institutes, Pharmaceutical and Biotechnology Companies
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Thermo Fisher Scientific
- Abcam
- Merck KGaA
- Agarose Bead Technologies
- ...
Highlights of The Immunoprecipitation Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Individual IP
- Coimmunoprecipitation
- CHIP
- By Application:
- Academics
- Research Institutes
- Pharmaceutical and Biotechnology Companies
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Immunoprecipitation Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Immunoprecipitation is a technique used to isolate proteins from a sample. Proteins can be isolated by affinity chromatography using an antibody against the protein of interest.
Some of the key players operating in the immunoprecipitation market are Thermo Fisher Scientific, Abcam, Merck KGaA, Agarose Bead Technologies.
The immunoprecipitation market is expected to register a CAGR of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Immunoprecipitation Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Immunoprecipitation Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Immunoprecipitation Market - Supply Chain
4.5. Global Immunoprecipitation Market Forecast
4.5.1. Immunoprecipitation Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Immunoprecipitation Market Size (000 Units) and Y-o-Y Growth
4.5.3. Immunoprecipitation Market Absolute $ Opportunity
5. Global Immunoprecipitation Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Immunoprecipitation Market Size and Volume Forecast by Type
5.3.1. Individual IP
5.3.2. Coimmunoprecipitation
5.3.3. CHIP
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Immunoprecipitation Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Immunoprecipitation Market Size and Volume Forecast by Application
6.3.1. Academics
6.3.2. Research Institutes
6.3.3. Pharmaceutical and Biotechnology Companies
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Immunoprecipitation Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Immunoprecipitation Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Immunoprecipitation Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Immunoprecipitation Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Immunoprecipitation Demand Share Forecast, 2019-2029
9. North America Immunoprecipitation Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Immunoprecipitation Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Immunoprecipitation Market Size and Volume Forecast by Application
9.4.1. Academics
9.4.2. Research Institutes
9.4.3. Pharmaceutical and Biotechnology Companies
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Immunoprecipitation Market Size and Volume Forecast by Type
9.7.1. Individual IP
9.7.2. Coimmunoprecipitation
9.7.3. CHIP
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Immunoprecipitation Demand Share Forecast, 2019-2029
10. Latin America Immunoprecipitation Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Immunoprecipitation Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Immunoprecipitation Market Size and Volume Forecast by Application
10.4.1. Academics
10.4.2. Research Institutes
10.4.3. Pharmaceutical and Biotechnology Companies
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Immunoprecipitation Market Size and Volume Forecast by Type
10.7.1. Individual IP
10.7.2. Coimmunoprecipitation
10.7.3. CHIP
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Immunoprecipitation Demand Share Forecast, 2019-2029
11. Europe Immunoprecipitation Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Immunoprecipitation Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Immunoprecipitation Market Size and Volume Forecast by Application
11.4.1. Academics
11.4.2. Research Institutes
11.4.3. Pharmaceutical and Biotechnology Companies
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Immunoprecipitation Market Size and Volume Forecast by Type
11.7.1. Individual IP
11.7.2. Coimmunoprecipitation
11.7.3. CHIP
11.8. Basis Point Share (BPS) Analysis by Tpe
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Immunoprecipitation Demand Share, 2019-2029
12. Asia Pacific Immunoprecipitation Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Immunoprecipitation Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Immunoprecipitation Market Size and Volume Forecast by Application
12.4.1. Academics
12.4.2. Research Institutes
12.4.3. Pharmaceutical and Biotechnology Companies
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Immunoprecipitation Market Size and Volume Forecast by Type
12.7.1. Individual IP
12.7.2. Coimmunoprecipitation
12.7.3. CHIP
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Immunoprecipitation Demand Share, 2019-2029
13. Middle East & Africa Immunoprecipitation Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Immunoprecipitation Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Immunoprecipitation Market Size and Volume Forecast by Application
13.4.1. Academics
13.4.2. Research Institutes
13.4.3. Pharmaceutical and Biotechnology Companies
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Immunoprecipitation Market Size and Volume Forecast by Type
13.7.1. Individual IP
13.7.2. Coimmunoprecipitation
13.7.3. CHIP
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Immunoprecipitation Demand Share, 2019-2029
14. Competition Landscape
14.1. Global Immunoprecipitation Market: Market Share Analysis
14.2. Immunoprecipitation Distributors and Customers
14.3. Immunoprecipitation Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Thermo Fisher Scientific
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Abcam
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Merck KGaA
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Agarose Bead Technologies
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. ...
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. COMPANY6
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. COMPANY7
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. COMPANY8
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook